- Home
- TGS vs HTFL Comparison
TGS vs HTFL Comparison
Compare TGS & HTFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGS
- HTFL
- Stock Information
- Founded
- TGS 1992
- HTFL 2007
- Country
- TGS Argentina
- HTFL United States
- Employees
- TGS N/A
- HTFL N/A
- Industry
- TGS Natural Gas Distribution
- HTFL
- Sector
- TGS Utilities
- HTFL
- Exchange
- TGS Nasdaq
- HTFL Nasdaq
- Market Cap
- TGS 3.4B
- HTFL 2.8B
- IPO Year
- TGS N/A
- HTFL 2025
- Fundamental
- Price
- TGS $30.94
- HTFL $38.30
- Analyst Decision
- TGS Strong Buy
- HTFL Strong Buy
- Analyst Count
- TGS 1
- HTFL 4
- Target Price
- TGS $40.00
- HTFL $37.00
- AVG Volume (30 Days)
- TGS 576.0K
- HTFL 343.5K
- Earning Date
- TGS 10-23-2025
- HTFL 11-12-2025
- Dividend Yield
- TGS 3.00%
- HTFL N/A
- EPS Growth
- TGS 69.56
- HTFL N/A
- EPS
- TGS 0.35
- HTFL N/A
- Revenue
- TGS $1,027,524,722.00
- HTFL $148,540,000.00
- Revenue This Year
- TGS N/A
- HTFL $34.51
- Revenue Next Year
- TGS N/A
- HTFL $24.58
- P/E Ratio
- TGS $18.10
- HTFL N/A
- Revenue Growth
- TGS 2.37
- HTFL 44.32
- 52 Week Low
- TGS $19.74
- HTFL $26.56
- 52 Week High
- TGS $34.37
- HTFL $41.22
- Technical
- Relative Strength Index (RSI)
- TGS 75.42
- HTFL N/A
- Support Level
- TGS $21.26
- HTFL N/A
- Resistance Level
- TGS $32.74
- HTFL N/A
- Average True Range (ATR)
- TGS 1.69
- HTFL 0.00
- MACD
- TGS 1.00
- HTFL 0.00
- Stochastic Oscillator
- TGS 84.60
- HTFL 0.00
About TGS Transportadora de Gas del Sur SA TGS
Transportadora de Gas del Sur SA is a transporters of natural gas in Latin America. The company's operating segments include Natural Gas Transportation, Midstream, Telecommunications, Production and Commercialization Liquids, Other Services, and Telecommunications. It generates maximum revenue from the Production and Commercialization of the Liquids segment. Geographically, it derives the majority of its revenue from Argentina.
About HTFL Heartflow Inc. Common Stock
HeartFlow Inc is a commercial-stage medical technology company that has pioneered the use of software and AI to deliver a non-invasive solution for diagnosing and managing coronary artery disease CAD. The company operates and manages its business as one reportable and operating segment, which is the business of non-invasive coronary artery disease detection solutions. Geographically, it operates in United States, United Kingdom, Japan, and Rest of Europe, of which it derives maximum revenue from United States.